| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.36▼ | 3.38▼ | 3.44▼ | 3.60▼ | 3.45▼ |
| MA10 | 3.45▼ | 3.47▼ | 3.50▼ | 3.61▼ | 3.35▼ |
| MA20 | 3.51▼ | 3.54▼ | 3.61▼ | 3.47▼ | 3.78▼ |
| MA50 | 3.63▼ | 3.65▼ | 3.69▼ | 3.31▼ | 5.99▼ |
| MA100 | 3.71▼ | 3.46▼ | 3.33▼ | 3.95▼ | 35.03▼ |
| MA200 | 3.32▼ | 3.45▼ | 3.33▼ | 5.47▼ | 59.68▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.021▼ | -0.024▼ | -0.038▼ | -0.010▼ | 0.407▲ |
| RSI | 21.809▼ | 29.624▼ | 32.457▼ | 46.778▼ | 38.829▼ |
| STOCH | 3.750▼ | 5.139▼ | 22.810 | 43.121 | 52.071 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -75.962▼ | -47.879 |
| CCI | -121.702▼ | -144.321▼ | -167.416▼ | -106.749▼ | 23.157 |
|
Tuesday, December 16, 2025 12:05 AM
FLORHAM PARK, N.J. and LANSING, Mich., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...
|
|
Thursday, November 13, 2025 12:43 PM
Caruso indicated plans to submit the application for conditional marketing approval in the EU in the middle of 2026, estimating "an approximately 12-month review... that's an approximately middle of ...
|
|
Wednesday, November 12, 2025 04:03 AM
Cellectar Biosciences (NASDAQ:CLRB) is set to give its latest quarterly earnings report on Thursday, 2025-11-13. Here's what investors need to know before the announcement. Analysts estimate that ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/01/26 | 3.44 | 3.47 | 3.20 | 3.31 | 75,183 |
| 27/01/26 | 3.51 | 3.695 | 3.38 | 3.54 | 37,224 |
| 26/01/26 | 3.65 | 3.7399 | 3.46 | 3.54 | 48,252 |
| 23/01/26 | 3.89 | 3.89 | 3.69 | 3.79 | 26,701 |
| 22/01/26 | 3.68 | 3.98 | 3.68 | 3.81 | 47,496 |
| 21/01/26 | 3.46 | 3.71 | 3.46 | 3.65 | 39,257 |
| 20/01/26 | 3.54 | 3.61 | 3.33 | 3.50 | 63,556 |
| 16/01/26 | 3.62 | 3.6905 | 3.53 | 3.59 | 36,261 |
| 15/01/26 | 3.74 | 3.74 | 3.5001 | 3.65 | 74,934 |
| 14/01/26 | 4.06 | 4.06 | 3.635 | 3.745 | 197,431 |
|
|
||||
|
|
||||
|
|